logo
logo
Sign in

Transplant Diagnostics Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2028

avatar
Chetan Khachne
Transplant Diagnostics Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2028

The global transplant diagnostics market size is expected to reach USD 7.08 billion by 2028 at a CAGR of 7.5%, according to the latest report by Reports and Data. Global market revenue growth is majorly attributed to surging number of organ transplantation procedures, rise in awareness about organ donation, increasing burden of infectious diseases, and surging prevalence of chronic diseases worldwide. Rising adoption of pre-transplant diagnostics, growing demand for high-throughput transplant diagnostic tools, technological advancements in diagnostic solutions, and rising cases of complications associated with organ transplantation are other crucial factors driving demand for transplant diagnostics.

Transplant diagnostics are diagnostic tools and techniques used to improve the effectiveness of transplantation procedures. These techniques are extensively used in pre-transplant screening for donor eligibility, immunogenetics testing, Human Leukocyte Antigen (HLA) tests, etc. They further help to identify post-transplant acute rejection and aid in the management of immunosuppression levels in transplant patients. Furthermore, these tests eliminate chances of several complications such as infection or graft failure. Rising adoption of next-Generation Sequencing (NGS) technology for their advantages over traditional methods like HLA typing, growing adoption of personalized medicine and stem cell therapy, and rise in government funding for healthcare R&D activities are expected to continue to support market growth going ahead.

Top Companies Profiled in the Report Include:

 Thermo Fisher Scientific Inc., F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., Abbott Laboratories, Immucor Transplant Diagnostics, Inc., Qiagen N.V., BioMérieux SA, GenDx, Omixon Ltd., Illumina, Inc., Affymetrix, Inc., CareDx, Luminex Corporation, Hologic Inc., Becton, Dickinson and Company, CareDx, Biofortuna, Takara Bio, and BAG Healthcare.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4039

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4039

The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Transplant Diagnostics market in these key regions.

Country-wise regional analysis covers:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

To know more about the report @ https://www.reportsanddata.com/press-release/global-transplant-diagnostics-market

Additionally, the report consists a detailed analysis of the segmentation of the Transplant Diagnostics market based on product types and end-use/application offered in the Transplant Diagnostics market.

By Product Type (Revenue, USD Billion; 2018-2028)

  • Instruments
  • Reagents & Consumables
  • Software & Services

By Technology Type (Revenue, USD Billion; 2018-2028)

  • Molecular Assay Technologies
    • PCR-based Molecular Assays
      • Real-time PCR
      • Sequence-specific Oligonucleotide-PCR
      • Sequence-specific Primer-PCR
      • Others
    • Sequencing-based Molecular Assays
      • Next-generation Sequencing
      • Sanger Sequencing
      • Others
    • Non-molecular Assay Technologies

By Transplant Type (Revenue, USD Billion; 2018-2028)

  • Solid Organ Transplantation
    • Heart Transplantation
    • Lung Transplantation
    • Liver Transplantation
    • Kidney Transplantation
    • Pancreas Transplantation
    • Others
  • Bone marrow Transplantation
  • Stem Cell Transplantation
  • Soft Tissue Transplantation

By Application (Revenue, USD Billion; 2018-2028)

  • Diagnostic Applications
    • Pre-transplantation Diagnostics
      • Blood Profiling
      • Infectious Disease Testing
      • Histocompatibility Testing
    • Post-transplantation Diagnostics
  • Research Applications

By End-use (Revenue, USD Billion; 2018-2028)

  • Hospitals & Transplant Centers
  • Independent Reference Laboratories
  • Research Laboratories & Academic Institutes
  • Others

Read More Reports

Creatinine Measurement Market @ https://www.biospace.com/article/creatinine-measurement-market-size-to-value-at-usd-841-01-million-in-2028/

Point of Care Glucose Testing Market @ https://www.biospace.com/article/point-of-care-glucose-testing-market-size-to-reach-usd-8-17-billion-in-2028-says-reports-and-data-/

Transfer Membrane Market @ https://www.biospace.com/article/transfer-membrane-market-size-to-reach-usd-204-75-million-in-2028-noted-reports-and-data/

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.   

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                       

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

 

collect
0
avatar
Chetan Khachne
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more